Interleukin-7 (Human, Recombinant)

Product Description

Interleukin-7 (Human, Recombinant)
Catalog number: B2010314
Lot number: Batch Dependent
Expiration Date: Batch dependent
Volume/Weight: 10 ug
pH: 7.4 upon reconstitution
Supplied as: Lyophilized Powder
Appearance: Powder
Applications: highly pure Interleukin-7 (Human, Recombinant) expressed in E. coli. This protein acts as a hematopoietic cytokine that promotes T-cell recovery after allogeneic stem cell transplantation.
Storage: -20C
Keywords: rHuIL-9; Cytokine P40; T-cell Growth Factor P40
Grade: Biotechnology grade. All components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Nguyen V, Mendelsohn A, Larrick JW. Interleukin-7 and Immunosenescence. J
Immunol Res. 2017;2017:4807853.

2: Barata JT, Durum SK, Seddon B. Flip the coin: IL-7 and IL-7R in health and
disease. Nat Immunol. 2019 Dec;20(12):1584-1593.

3: Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic
application. Nat Rev Immunol. 2011 May;11(5):330-42.

4: Hossny EM, El-Ghoneimy DH, El-Owaidy RH, Mansour MG, Hamza MT, El-Said AF.
Breast milk interleukin-7 and thymic gland development in infancy. Eur J Nutr.
2020 Feb;59(1):111-118.

5: Tian X, Su Z, Guo S, Wang C, Zhang X, Du J. Interleukin-7 promotes
CD8⁺ T cell activity in patients with enterovirus 71 associated
encephalitis. Int Immunopharmacol. 2019 Oct;75:105773.

6: Li S, Wang Z, Zhang G, Fu J, Zhang X. Interleukin-7 promotes lung-resident
CD14⁺ monocytes activity in patients with lung squamous carcinoma.
Int Immunopharmacol. 2019 Feb;67:202-210.

7: Zhang ZH, Jiang BC, Liu XH, Zhang MX, Li ZS, Zhu GZ. Interleukin-7 Regulates
T Follicular Helper Cell Function in Patients with Chronic Hepatitis C. Viral
Immunol. 2018 Jul/Aug;31(6):417-425.

8: Javvaji PK, Dhali A, Francis JR, Kolte AP, Mech A, Sathish L, Roy SC.
Interleukin 7 improves in vitro maturation of ovine cumulus-oocyte complexes in
a dose dependent manner. Cytokine. 2019 Jan;113:296-304.

9: Monneret G, Villars-Méchin A, Demaret J, Foray AP, Venet F. L’interleukine 7
comme thérapeutique immuno-adjuvante dans le traitement du choc septique
[Interleukin-7, a new immunoadjuvant for the treatment of septic shock]. Med Sci
(Paris). 2014 Feb;30(2):160-5.
10: Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent
design. Nat Rev Immunol. 2007 Feb;7(2):144-54.

Products Related to Interleukin-7 (Human, Recombinant) : Proteins